Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal - The Wall Street Journal

Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal  The Wall Street Journal

Gilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company's treatments in ...

View full coverage on Google News

from Top stories - Google News https://ift.tt/2NUNtjO